Although this study provides a pan-cancer map of putative TF regulators, the prognostic and mechanistic relevance of central hubs, particularly MYC, TAF1, and EGR1, requires validation in future studies using independent, cancer type–specific cohorts such as those available from TCGA. The gene discussed is EGR1; the disease is cancer.